Anxiety ,Stress, and Depression


Psychosomatic Medication Conference focusses on Functional somatic syndromes with depression and anxiety are of moderate magnitude but were highly significant statistically as when compared with a healthy person and which controls with medical disorders of known organic pathology. So it is very important to evaluate the medical causes where anxiety is accompanied by disproportionate physical symptoms like Tachycardia or atypical physical symptom like confusion. The main psychosomatic therapy which is known as Cognitive behavioral therapy (CBT) should be concerned as a first-line treatment for situational anxiety and also anxiety disorders. The use of Benzodiazepines which can help to improve primary anxiety in a short term and Tricyclic Antidepressants like Mirtazapine was also considered. Selective serotonin reuptake inhibitors, selective norepinephrine reuptake inhibitors were also used in psychosomatic therapies.


    Related Conference of Anxiety ,Stress, and Depression

    March 18-19, 2024

    34th Euro Congress on Psychiatrists and Psychologists

    Zurich, Switzerland
    April 11-12, 2024

    4th Annual Congress on Mental Health

    Amsterdam, Netherlands
    May 23-24, 2024

    41th Global Psychiatry and Mental Health Conference

    Zurich, Switzerland
    May 27-28, 2024

    6th European Autism Congress

    Paris, France
    July 15-16, 2024

    6th International Congress on Mental Health

    Amsterdam, Netherlands
    September 09-10, 2024

    5th Annual Congress on Psychiatry

    London, UK

    Anxiety ,Stress, and Depression Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in